Biliary proteins and their redox status changes in gallstone patients: Relation to stone composition and cholesterol crystallization

European Journal of Clinical Investigation

Volumn 39, Issue 11, 2009, Pages 986-992

  Grattagliano, I ^a   Wang, D Q H ^b   Di Ciaula, A ^c   Diogo, C V ^d   Palasciano, G ^a   Portincasa, P ^a  

^a UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c Division of Internal Medicine   (Italy)

^d UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Bile; Monohydrate cholesterol; Protein carbonyls; Protein sulfhydryls

Indexed keywords

BILE ACID; BILIARY TRACT PROTEIN; CARBONYL DERIVATIVE; CHOLESTEROL; LIPID; PIGMENT; PROTEIN; THIOL DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CHOLECYSTECTOMY; CHOLESTEROL BILE LEVEL; CHOLESTEROL EMBOLISM; CHOLESTEROL SATURATION INDEX; CONTROLLED STUDY; CRYSTALLIZATION; GALLSTONE; GALLSTONE FORMATION; HUMAN; HUMAN CELL; HUMAN TISSUE; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; SPECTROPHOTOMETRY;

ADULT; BILE; CHOLELITHIASIS; CHOLESTEROL; FEMALE; HUMANS; MALE; MICROSCOPY, POLARIZATION; MIDDLE AGED; OXIDATION-REDUCTION; PROTEINS;

EID: 70349970358     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2009.02187.x     Document Type: Article

References (50)

1. Portincasa P, Moschetta A, Palasciano G. Cholesterol gallstone disease. Lancet 2006 368 : 230 239.
2. Everhart JE, Yeh F, Lee ET, Hill MC, Fabsitz R, Howard BV, et al. Prevalence of gallbladder disease in American Indian populations: findings from the Strong Heart Study. Hepatology 2002 35 : 1507 1512.
3. Sandler RS, Everhart JE, Donowitz M, Adams E, Cronin K, Goodman C, et al. The burden of selected digestive diseases in the United States. Gastroenterology 2002 122 : 1500 1511.
4. Wang DQH, Afdhal NH. Genetic analysis of cholesterol gallstone formation: searching for Lith (gallstone) genes. Curr Gastroenterol Rep 2004 6 : 140 150.
5. Diehl AK. Epidemiology and natural history of gallstone disease. Gastroenterol Clin North Am 1991 20 : 1 19.
6. Portincasa P, Di Ciaula A., Wang HH, Palasciano G, van Erpecum KJ, Moschetta A, et al. Coordinate regulation of gallbladder motor function in the gut-liver axis. Hepatology 2008 47 : 2112 2126.
7. Wang HH, Portincasa P, Wang DQ. Molecular pathophysiology and physical chemistry of cholesterol gallstones. Front Biosci 2008 13 : 401 423.
8. Jungst C, Sreejayan N, Eder MI, von SN, Zundt B, Spelsberg FW, et al. Lipid peroxidation and mucin secretagogue activity in bile of gallstone patients. Eur J Clin Invest 2007 37 : 731 736.
9. Sheen PC, Lee KT, Liu YE. Mucin content in gallbladders with brown pigment stones or combination stones with a brown periphery. Digestion 1998 59 : 660 664.
10. Holan KR, Holzbach RT, Hermann RE, Cooperman AM, Claffey WJ. Nucleation time: a key factor in the pathogenesis of cholesterol gallstone disease. Gastroenterology 1979 77 : 611 617.
11. van Erpecum KJ, van Berge-Henegouwen GP, Stoelwinder B, Stolk MF, Eggink WF, Govaert WH. Cholesterol and pigment gallstone disease: comparison of the reliability of three bile tests for differentiation between the two stone types. Scand J Gastroenterol 1988 23 : 948 954.
12. van Erpecum KJ, van Berge-Henegouwen GP, Stoelwinder B, Schmidt YMG, Willekens FLH. Bile concentration is a key factor for nucleation of cholesterol crystals and cholesterol saturation index in gallbladder bile of gallstone patients. Hepatology 1990 11 : 1 6.
13. Portincasa P, van Erpecum KJ, Jansen A, Renooij W, Gadellaa M, van Berge-Henegouwen GP. Behavior of various cholesterol crystals in bile from gallstone patients. Hepatology 1996 23 : 738 748.
14. van Erpecum KJ, Portincasa P, Eckhardt E, Go PMNYH, van Berge-Henegouwen GP, Groen AK. Ursodeoxycholic acid reduces protein levels and their nucleation-promoting activity in gallbladder bile. Gastroenterology 1996 110 : 1225 1237.
15. Wilhelmi M, Jungst C, Mock M, Meyer G, Zundt B, Del PR, et al. Effect of gallbladder mucin on the crystallization of cholesterol in bile. Eur J Gastroenterol Hepatol 2004 16 : 1301 1307. (Pubitemid 39627529)
16. Geetha A. Evidence for oxidative stress in the gall bladder mucosa of gall stone patients. J Biochem Mol Biol Biophys 2002 6 : 427 432.
17. Soloway RD, Weinman SA. Oxidative stress as a cause of biliary lithiasis: new possibilities for medical therapy of stones or a false alarm? Hepatology 2000 32 : 670 671.
18. Simon JA, Hudes ES. Serum ascorbic acid and gallbladder disease prevalence among US adults: the Third National Health and Nutrition Examination Survey (NHANES III). Arch Intern Med 2000 160 : 931 936.
19. Gustafsson U, Wang FH, Axelson M, Kallner A, Sahlin S, Einarsson K. The effect of vitamin C in high doses on plasma and biliary lipid composition in patients with cholesterol gallstones: Prolongation of the nucleation time. Eur J Clin Invest 1997 27 : 387 391.
20. Elek G, Rockenbauer A. The free radical signal of pigment gallstones. Klin Wochenschr 1982 60 : 33 5.
21. Stadtman ER, Levine RL. Protein oxidation. Ann N Y Acad Sci 2000 899 : 191 208.
22. Grattagliano I, Russmann S, Palmieri VO, Juni P, Bihl F, Portincasa P, et al. Low membrane protein sulfhydrils but not G6PD deficiency predict ribavirin-induced hemolysis in hepatitis C. Hepatology 2004 39 : 1248 1255.
23. Jirsa M, Groen AK. Role of biliary proteins and non-protein factors in kinetics of cholesterol crystallisation and gallstone growth. Front Biosci 2001 6 : E154 E167.
24. Gallinger S, Harvey PRC, Petrunka CN, Ilson RG, Strasberg SM. Biliary proteins and the nucleation defect in cholesterol cholelithiasis. Gastroenterology 1987 92 : 867 875.
25. Tudyka J, Kratzer W, Kuhn K, Mason R, Wechsler JG, Adler G. Solitary versus multiple gallstones: the importance of total biliary protein concentration and other factors. Hepatogastroenterology 1995 42 : 638 644.
26. van Erpecum KJ, Portincasa P, Dohlu MH, van Berge-Henegouwen GP, Jungst D. Biliary pronucleating proteins and apolipoprotein E in cholesterol and pigment stone patients. J Hepatol 2003 39 : 7 11.
27. Portincasa P, Di Ciaula A, Vendemiale G, Palmieri VO, Moschetta A, van Berge-Henegouwen GP, et al. Gallbladder motility and cholesterol crystallization in bile from patients with pigment and cholesterol gallstones. Eur J Clin Invest 2000 30 : 317 324.
28. Trotman BW, Ostrow JD, Soloway RD. Pigment vs cholesterol cholelithiasis: comparison of stone type and bile composition. Am J Dig Dis 1974 19 : 585 590.
29. Tera H Stratification of human gallbladder in vivo. Acta Chir Scand 1960 suppl 256 : 4 85.
30. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959 37 : 911 917.
31. Wang DQH, Carey MC. Complete mapping of crystallization pathways during cholesterol precipitation from model bile: influence of physical-chemical variables of pathophysiologic relevance and identification of a stable liquid crystalline state in cold, dilute and hydrophilic bile salt-containing system. J Lipid Res 1996 37 : 606 630.
32. Fromm H, Hamin P, Klein H, Kupke I. Use of a simple enzymatic assay for cholesterol analysis in human bile. J Lipid Res 1980 21 : 259 261.
33. Turley SD, Dietschy JM. Reevaluation of the 3α-hydroxy-steroid dehydrogenase assay for total bile acids in bile. J Lipid Res 1978 19 : 924 928.
34. Carey MC. Critical tables for calculating the cholesterol saturation of native bile. J Lipid Res 1978 19 : 945 955.
35. Grattagliano I, Vendemiale G, Sabba C, Buonamico P, Altomare E. Oxidation of circulating proteins in alcoholics: role of acetaldehyde and xanthine oxidase. J Hepatol 1996 25 : 28 36.
36. Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz AG, et al. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 1990 186 : 464 478.
37. Armitage P, Berry G Statistical methods in medical research, Oxford : Blackwell Science Ltd, 1994.
38. Dawson B, Trapp RG Basic & Clinical Biostatistics, New York : McGraw-Hill, 2001.
39. Groen AK, Stout JPJ, Drapers JAG, Hoek FJ, Grijm R, Tytgat GNJ. Cholesterol nucleation influencing activity in T-tube bile. Hepatology 1988 8 : 347 352.
40. Boisier X, Schon M, Sepulveda A, Basualdo A, Cornejo P, Bosco C, et al. Derangement of Kupffer cell functioning and hepatotoxicity in hyperthyroid rats subjected to acute iron overload. Redox Rep 1999 4 : 243 250.
41. Shiesh SC, Chen CY, Lin XZ, Liu ZA, Tsao HC. Melatonin prevents pigment gallstone formation induced by bile duct ligation in guinea pigs. Hepatology 2000 32 : 455 460.
42. Swartz-Basile DA, Goldblatt MI, Blaser C, Decker PA, Ahrendt SA, Sarna SK, et al. Iron deficiency diminishes gallbladder neuronal nitric oxide synthase. J Surg Res 2000 90 : 26 31.
43. Johnston SM, Murray KP, Martin SA, Fox-Talbot K, Lipsett PA, Lillemoe KD, et al. Iron deficiency enhances cholesterol gallstone formation. Surgery 1997 122 : 354 361.
44. Lin C, Shen T, Fu X, Zhou X. The ability of bile to scavenge superoxide radicals and pigment gallstone formation in guinea pigs. HPB Surg 1996 10 : 73 6.
45. Carey MC. Pathogenesis of gallstones. Am J Surg 1993 165 : 410 419.
46. Brink MA, Slors JF, Keulemans YC, Mok KS, De Waart DR, Carey MC, et al. Enterohepatic cycling of bilirubin: a putative mechanism for pigment gallstone formation in ileal Crohn's disease. Gastroenterology 1999 116 : 1420 1427.
47. Sandstad O, Osnes T, Urdal P, Skar V, Osnes M. Brown pigment stones in the common bile duct: reduced bilirubinate diconjugate in bile. Scand J Gastroenterol 2000 35 : 198 203.
48. Sedlak TW, Saleh M, Higginson DS, Paul BD, Juluri KR, Snyder SH. Bilirubin and glutathione have complementary antioxidant and cytoprotective roles. Proc Natl Acad Sci U S A 2009 106 : 5171 5176.
49. Holloway DE, Rivers JM. Influence of chronic ascorbic acid deficiency and excessive ascorbic acid intake on bile acid metabolism and bile composition in the guinea pig. J Nutr 1981 111 : 412 424.
50. Peters WH, van SA, Peters JH, van GH. Oxidised- and total non-protein bound glutathione and related thiols in gallbladder bile of patients with various gastrointestinal disorders. BMC Gastroenterol 2007 7 : 7.